4//SEC Filing
Dubin Glenn 4
Accession 0001662579-23-000059
CIK 0001662579other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:23 PM ET
Size
5.4 KB
Accession
0001662579-23-000059
Insider Transaction Report
Form 4
Dubin Glenn
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-15+26,000→ 26,000 totalExercise: $3.61Exp: 2033-06-14→ Common Stock (26,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2024 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001308597
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:23 PM ET
- Size
- 5.4 KB